Jennifer J Griggs, MD, MPH, FACP, FASCO
Professor of Internal Medicine
Professor of Health Management and Policy
North Campus Research Complex
2800 Plymouth Rd, Building 14, G226
Ann Arbor, MI 48109-2800
[email protected]

Available to mentor
Jennifer J Griggs, MD, MPH, FACP, FASCO
Professor
  • Center Memberships
  • Recent Publications
    • Center Memberships
    • Center Member
      Rogel Cancer Center
    • Center Member
      Institute for Healthcare Policy and Innovation
    • Center Member
      Global REACH
    Recent Publications See All Publications
    • Proceeding / Abstract / Poster
      Associations between interpersonal violence and cancer risk factors for transgender and cisgender people.
      Alpert AB, Sayegh SJ, Strawderman MS, Cunliffe S, Cupertino AP, Griggs JJ, Cerulli C. JOURNAL OF CLINICAL ONCOLOGY, 2022 40 (16):
    • Proceeding / Abstract / Poster
      Cancer risk factors and cancer in transgender versus cisgender people: Real-world data from a tertiary health care institution.
      Alpert AB, Sayegh SJ, Strawderman MS, Cunliffe S, Cupertino AP, Cerulli C, Griggs JJ. JOURNAL OF CLINICAL ONCOLOGY, 2022 40 (16):
    • Proceeding / Abstract / Poster
      Family history assessment to identify patients at risk for hereditary cancer syndromes in community oncology practices.
      Austin S, Hanson E, Griggs JJ, Resnicow K, Stoffel EM. JOURNAL OF CLINICAL ONCOLOGY, 2022 40 (16): E18735 - E18735.
    • Proceeding / Abstract / Poster
      Oncologist knowledge of cost of genetic testing.
      Weiner S, Austin S, Carr G, Kidwell KM, Resnicow K, Stoffel EM, Griggs JJ. JOURNAL OF CLINICAL ONCOLOGY, 2022 40 (16):
    • Proceeding / Abstract / Poster
      Obesity and Angiolymphatic Invasion in Primary Breast Cancer.
      Griggs J, Gillespie E, Hanauer D, Jagielski C, Sabel M, Sorbero M. Cancer Research, 2009 Dec 15; 69 (24_Supplement): 5151 - 5151. DOI:10.1158/0008-5472.sabcs-09-5151
    • Journal Article
      Trends in chemotherapy use for early-stage breast cancer from 2006 to 2019.
      Bhimani J, O'Connell K, Ergas IJ, Foley M, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Persaud S, Rivera DR, Roh JM, Tabatabai S, Valice E, Bowles EJA, Bandera EV, Kushi LH, Kantor ED. Breast Cancer Res, 2024 Jun 13; 26 (1): 101 DOI:10.1186/s13058-024-01822-9
      PMID: 38872192
    • Journal Article
      Patient characteristics associated with delayed time to adjuvant chemotherapy among women treated for stage I-IIIA breast cancer.
      Bhimani J, O'Connell K, Persaud S, Blinder V, Burganowski R, Ergas IJ, Foley MJ, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Rivera DR, Roh JM, Tabatabai S, Valice E, Bandera EV, Bowles EJA, Kushi LH, Kantor ED. Int J Cancer, 2024 Nov 1; 155 (9): 1577 - 1592. DOI:10.1002/ijc.35053
      PMID: 38970396
    • Journal Article
      The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery system.
      Bhimani J, O'Connell K, Persaud S, Blinder V, Burganowski RP, Ergas IJ, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Rivera DR, Roh JM, Tabatabai S, Valice E, Bandera EV, Aiello Bowles EJ, Kushi LH, Kantor ED. Breast Cancer Res Treat, 2024 Nov; 208 (2): 405 - 414. DOI:10.1007/s10549-024-07433-4
      PMID: 39150586